tiprankstipranks
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC
UK Market
AREC
Arecor Therapeutics PLC
RESEARCH TOOLSreports
Want to see GB:AREC full AI Analyst Report?

Arecor Therapeutics PLC (AREC) Income Statement

6 Followers

Arecor Therapeutics PLC Income Statement

Last quarter (Q4 2025), Arecor Therapeutics PLC's total revenue was £-289.00K, a decrease of -109.95% from the same quarter last year. In Q4, Arecor Therapeutics PLC's net income was £3.17M. See Arecor Therapeutics PLC’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 1.71M£ 5.05M£ 4.57M£ 2.40M£ 1.16M
Gross Profit
£ 1.05M£ 1.54M£ 4.57M£ 2.40M£ 1.16M
Operating Expenses
£ 5.65M£ 12.24M£ 13.75M£ 12.91M£ 7.13M
Depreciation and Amortization
£ 215.00K£ 446.00K£ 496.00K£ 341.00K£ 171.00K
EBITDA
£ -4.39M£ -10.15M£ -8.39M£ -10.06M£ -6.27M
Operating Income
£ -4.60M£ -10.70M£ -9.18M£ -11.66M£ -5.98M
Other Income/Expenses
£ 5.60M£ 79.00K£ 274.00K£ 88.00K£ -506.00K
Pretax Income
£ 994.00K£ -10.62M£ -8.90M£ -10.54M£ -6.95M
Net Income
£ 664.00K£ -10.24M£ -8.55M£ -9.26M£ -6.17M
Per Share Metrics
Basic EPS
£ 0.02£ -0.33£ -0.28£ -0.32£ -0.27
Diluted EPS
£ 0.02£ -0.33£ -0.28£ -0.32£ -0.27
Weighted Average Shares Outstanding
 37.76M 33.44M 30.62M 28.94M 23.03M
Weighted Average Shares Outstanding (Diluted)
 39.44M 33.44M 30.62M 28.94M 23.03M
Currency in GBP

Arecor Therapeutics PLC Earnings and Revenue History